Aging Clinical and Experimental Research · Aug 18, 2026
Sex-based differences in glycaemic variability and clinical outcomes among older inpatients with type 2 diabetes: insights from the GLIMPACT study
By Confortin N, Ceolin C, Vergadoro M et al.
BACKGROUND: Glycaemic variability (GV) has emerged as a potential marker of adverse outcomes in hospitalised patients with diabetes, yet its clinical impact in older adults and the role of sex differences remain unclear. AIMS: To evaluate the association between in-hospital GV and length of stay (LOS) and one- and two-year all-cause mortality in older adults with type 2 diabetes, and to explore sex-specific patterns. METHODS: Retrospective observational study of patients aged ≥ 65 years with type 2 diabetes admitted to a geriatric unit (2018-2020). GV was assessed using the coefficient of variation (CV) of point-of-care glucose measurements (POCT). Multivariable linear regression and Cox proportional hazards models were applied, adjusting for relevant confounders, with analyses stratified by sex. RESULTS: A total of 283 patients (59.7% female, mean age 84.9 ± 6.9 years) were included. Higher GV was independently associated with longer LOS in the overall cohort (β = 0.194, 95% CI 0.078-0.310, p = 0.001) and in females, but not in males. Higher GV was associated with increased one-year mortality in females (HR = 1.02, 95% CI 1.00-1.04, p = 0.019), while an inverse association was observed in males. At two years, GV remained associated with mortality only in females. DISCUSSION: Sex differences in insulin sensitivity and counter-regulatory responses may partly explain these findings. The inverse association in males should be interpreted cautiously, possibly reflecting residual confounding from a higher prevalence of SARS-CoV-2 infection. CONCLUSION: In-hospital GV was associated with longer hospital stay and higher mortality in older adults with type 2 diabetes, particularly among females, suggesting it may represent a potential marker of clinical vulnerability warranting sex-specific approaches to glycaemic management.
doi.org/10.1007/s40520-026-03475-4Open accessPubMed 43052620Biomarkers